Increase in histone poly (ADP-ribosylation) in mitogen-activated lymphoid cells.
Poly (ADP-ribosylated) histones appear to be intermediates in nuclear processes that involve DNA strand breaks. We have studied histone ADP-ribosylation in cellular lysates from activated human lymphoid cells in culture. Modified histones differing in the number of ADP-ribose groups gave separate bands upon two-dimensional gel electrophoresis. Cellular lysates from control cells contained histones modified with 1 to 15 ADP-ribose groups. Stimulation of the cells during culture with phytohemagglutinin (PHA) or a phorbol ester (TPA) as well as combinations of these two reagents led to a significant increase in the upper limit number of ADP-ribose groups attached to histones in the presence of divalent metal ions. Hyper (ADP-ribosylated) H2B carrying at least 32 ADP-ribose groups gave a distinctly characteristic pattern on two-dimensional gels showing that highly ordered enzymatic steps are followed for its synthesis. Moreover, it was found that PHA and/or TPA induces branching of the poly (ADP-ribose) on H2B. The increase in histone poly (ADP-ribosylation) following lymphocyte activation was less dramatic during incubation of cellular lysates in the absence of divalent metal ions. The increased histone modification observed in this study may result from an increase in cell proliferation during activation of lymphoid cells. The finding that the number of ADP-ribose groups on H4 equals or exceeds by one the number of acetyl groups suggests that the two modifications may share common functions.
Boulikas
T
T
Linus Pauling Institute of Science and Medicine, Palo Alto, California 94306.
Bastin
B
B
Boulikas
P
P
Dupuis
G
G
D000001:Calcimycin / Q000494:pharmacology; D002460:Cell Line; D006657:Histones / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation; D009243:NAD / Q000378:metabolism*; D009702:Nucleoside Diphosphate Sugars / Q000378:metabolism*; D010835:Phytohemagglutinins / Q000494:pharmacology*; D011064:Poly Adenosine Diphosphate Ribose / Q000378:metabolism*; D013601:T-Lymphocytes; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism
D006657:Histones; D009702:Nucleoside Diphosphate Sugars; D010835:Phytohemagglutinins; D009243:NAD; D011064:Poly Adenosine Diphosphate Ribose; D000001:Calcimycin; D013755:Tetradecanoylphorbol Acetate